Loss-of-function mutations and variations of cathepsin D lead to multiple forms of neurodegeneration in humans (Steinfeld et al., 2006) and is related to the risk of late-onset AD (Davidson et al., 2006). Here, CTSD is linked to Alzheimer disease.